Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID

The present studies were supported by the European Research Council, Karolinska Institutet, Knut and Alice Wallenberg Foundation, Nordstjernan AB, Region Stockholm, and the Swedish Research Council.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2024-10-11
DOI
https://doi.org/10.1016/j.ebiom.2024.105385
Citations
10
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
3.89

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID

David Wullimann, Puran Chen, Smith Rjh, Sandra Muschiol et al.
10 citations
EBioMedicine
SARS-CoV-2 and COVID-19 Research
3.89
article

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID

David Wullimann, Puran Chen, Smith Rjh, Sandra Muschiol, Soo Aleman, Stephan Mielke, Anders Österborg, Mira Akber, Marcus Buggert, Karin Loré, Jan Vesterbacka, Peter Bergman, Ola Blennow, Lotta Hansson, Mikael Åberg, Per Ljungman, Gunnar Söderdahl, Angélica Cuapio, Hans‐Gustaf Ljunggren, Yu Gao, Gordana Bogdanović, Piotr Nowak, Margaret Chen
article en
10 citations

Abstract

The present studies were supported by the European Research Council, Karolinska Institutet, Knut and Alice Wallenberg Foundation, Nordstjernan AB, Region Stockholm, and the Swedish Research Council.

EBioMedicineVol. 109
Uppsala University (SE), Karolinska University Hospital (SE), Science for Life Laboratory (SE), Karolinska Institutet (SE)
Karolinska Institutet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, HORIZON EUROPE European Research Council
Good health and well-being
Openalex Percentile: Top 6%
SARS-CoV-2 and COVID-19 Research
3.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.